Experimental antibacterial therapy with puroindolines, lactoferrin and lysozyme in Listeria monocytogenes-infected mice

Microbes and Infection

Volumn 12, Issue 7, 2010, Pages 538-545

  Palumbo, Daniela ^a   Iannaccone, Marco ^a   Porta, Amalia ^b   Capparelli, Rosanna ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Dept of Pharmaceutical Sciences   (Italy)

Author keywords

Antimicrobial activity; Innate immunity; Listeria monocytogenes

Indexed keywords

C REACTIVE PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; CD8A ANTIGEN; CD8B ANTIGEN; FIBRINOGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; LYSOZYME; POLYPEPTIDE ANTIBIOTIC AGENT; PUROINDOLINE A; PUROINDOLINE B; PUROINDOLINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; GROWTH INHIBITION; INFECTION CONTROL; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; T LYMPHOCYTE;

ANIMALS; ANTI-BACTERIAL AGENTS; CYTOKINES; LACTOFERRIN; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MALE; MICE; MURAMIDASE; PLANT PROTEINS;

BACTERIA (MICROORGANISMS); BOVINAE; LISTERIA MONOCYTOGENES; MUS;

EID: 77953021354     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.03.010     Document Type: Article

References (45)

1. Faber J.M., and Peterkin P.I. Listeria monocytogenes, a food-borne pathogen. Microbiol. Rev. 55 (1991) 476-511
2. Cossart P., and Toledo-Arana A. Listeria monocytogenes, a unique model in infection biology: an overview. Microbes Infect. 10 (2008) 1041-1050
3. Charpentier E., and Courvalin P. Antibiotic resistance in Listeria spp. Antimicrobial. Agents Chemother. 43 (1999) 2103-2108
4. McGirt L.Y., and Beck L.A. Innate immune defects in atopic dermatitis. J. Allergy Clin. Immunol. 118 (2006) 202-208
5. Kurata S., Ariki S., and Kawabata S. Recognition of pathogens and activation of immune responses in Drosophila and horseshoe crab innate immunity. Immunobiology 211 (2006) 237-249
6. Tossi A., and Sandri L. Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. Curr. Pharm. Des. 8 (2002) 743-761
7. West N.P., Pyne D.B., Renshall G., and Cripps A.W. Antimicrobial peptides and proteins, exercise and innate mucosal immunity. FEMS Immunol. Med. Microbiol. 48 (2006) 293-304
8. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
9. Cunliffe R.N., Kamal M., and Rose F.R.A.J. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J. Clin. Pathol. 55 (2002) 298-304
10. Phadke S.M., Deslouches B., and Hileman S.E. Antimicrobial peptides in mucosal secretions: the importance of local secretions in mitigating infection. J. Nutr. 135 (2005) 1289-1293
11. Danilova N. The evolution of immune mechanisms. J. Exp. Zool. 306 (2006) 496-520
12. Capparelli R., Parlato M., Borriello G., Salvatore P., and Iannelli D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother. 51 (2007) 2765-2773
13. Charnet P., Molle G., Marion D., Rousset M., and Lullien-Pellerin V. Puroindolines form ion channels in biological membranes. Biophys. J. 84 (2003) 2416-2426
14. Llanos P., Henriquez M., Minic J., Elmoriani K., Marion D., Riquelme G., Molgò J., and Benoit E. Puroindoline-a and alpha1-purothionin form ion channels in giant liposomes but exert different toxic actions on murine cells. FEBS J. 273 (2006) 1710-1722
15. Arnold R.R., Cole M.F., and McGhee J.R. A bactericidal effect for human lactoferrin. Science 197 (1977) 263-265
16. Arnold R.R., Russell J.E., Champion W.J., Brewer M., and Gauthier J.J. Bactericidal activity of lactoferrin: differentiation from the stasis of iron deprivation. Infect. Immun. 35 (1982) 792-799
17. Legrand D., Elass E., Pierce A., and Mazurier J. Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals 17 (2004) 225-229
18. Ward P.P., Paz E., and Conneely O.M. Multifunctional roles of lactoferrin: a critical overview. Cell. Mol. Life Sci. 62 (2005) 2540-2548
19. Lahoz E., Pisacane A., Iannaccone M., Palumbo D., and Capparelli R. Fungistatic activity of iron free bovine lactoferrin against several fungal plant pathogens and antagonists. Nat. Prod. Res. 22 (2008) 955-961
20. Capparelli R., Ventimiglia I., Palumbo D., Nicodemo D., Salvatore P., Amoroso M.G., and Iannaccone M. Expression of recombinant puroindolines for the treatment of staphylococcal skin infections (Acne vulgaris). J. Biotechnol. 128 (2007) 279-284
21. Rosenfeld Y., Barra D., Simmaco M., Shai Y., and Mangoni M.L. A synergism between temporins toward Gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J. Biol. Chem. 281 (2006) 28565-28574
22. Palliser D., Chowdhury D., Wang Q.Y., Lee S.J., Bronson R.T., Knipe D.M., and Lieberman J. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439 (2006) 89-94
23. Lavi O., Louzoun Y., and Klement E. Listeriosis: a model for the fine balance between immunity and morbidity. Epidemiology 19 (2008) 581-587
24. Hancock R.E.W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1 (2001) 156-164
25. Blochet J.E., Chevalier C., Forest E., Pebay-Peyroula E., Gautier M.F., Joudrier P., Pézolet M., and Marion D. Complete amino acid sequence of puroindoline, a new basic and cystine-rich protein with a unique tryptophan-rich domain, isolated from wheat endosperm by Triton X-114 phase partitioning. FEBS Lett. 329 (1993) 336-340
26. Capparelli R., Amoroso M.G., Palumbo D., Iannaccone M., Faleri C., and Cresti M. Two plant puroindolines colocalize in wheat seed and in vitro synergistically fight against pathogens. Plant Mol. Biol. 58 (2005) 857-867
27. Mattei C., Elmorjani K., Molgó J., Marion D., and Benoit E. The wheat proteins puroindoline-a and alpha 1-purothionin induce nodal swelling in myelinated axons. NeuroReport 9 (1998) 3803-3807
28. Jing W., Demcoe A.R., and Vogel H.J. Conformation of a bactericidal domain of puroindoline a: structure and mechanism of action of a 13-residue antimicrobial peptide. J. Bacteriol. 185 (2003) 4938-4947
29. Krishnamurthy K., Balconi C., Sherwood J.E., and Giroux M.J. Wheat puroindolines enhance fungal disease resistance in transgenic rice. Mol. Plant Microbe Interact. 14 (2001) 1255-1260
30. Yamauchi K., Tomita M., Giehl T.J., and Ellison R.T. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61 (1993) 719-728
31. Bellamy W., Takase M., Wakabayashi H., Kawase K., and Tomita M. Antibacterial spectrum of lactoferricin-B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73 (1992) 472-479
32. Bellamy W., Yamauchi K., Wakabayashi H., Takase M., Takakura N., Shimamura S., and Tomita M. Antifungal properties of lactoferricin-B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett. Appl. Microbiol. 18 (1994) 230-233
33. Tomita M., Bellamy W., Takase M., Yamauchi K., Wakabayashi H., and Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 74 (1991) 4137-4142
34. van der Kraan M.I., Groenink J., Nazmi K., Veerman E.C., Bolscher J.G., and Amerongen A.V.N. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25 (2004) 177-183
35. Pellegrini A., Thomas U., Bramaz N., Klauser S., and von Fellenberg R. Identification and isolation of a bactericidal domain in chicken egg white lysozyme. J. Appl. Microbiol. 82 (1997) 372-378
36. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., and Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121 (1992) 130-136
37. Pellegrini A., Thomas U., Wild P., Schraner E., and von Fellenberg R. Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli. Microbiol. Res. 155 (2000) 69-77
38. Lepper P.M., Held T.K., Schneider E.M., Bolke E., Gerlach H., and Trautmann M. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med. 28 (2002) 824-833
39. Morrison D.C., and Ryan J.L. Endotoxin and disease mechanisms. Annu. Rev. Med. 38 (1987) 417-432
40. Remick D.G., Bolgos G.R., Siddiqui J., Shin J., and Nemzek J.A. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17 (2002) 463-467
41. Goulet V., and Marchetti P. Listeriosis in non-pregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions. Scand. J. Infect. Dis. 28 (1996) 367-374
42. Hof H., Nichterlein T., and Kretschmar M. Management of listeriosis. Clin. Microbiol. Rev. 10 (1997) 345-357
43. Temple M.E., and Nahata M.C. Treatment of listeriosis. Ann. Pharmacother. 34 (2000) 656-661
44. Capparelli R., Palumbo D., Iannaccone M., Ventimiglia I., Di Salle E., Capuano F., Salvatore P., and Amoroso M.G. Cloning and expression of two plant proteins: similar antimicrobial activity of native and recombinant form. Biotechnol. Lett. 28 (2006) 943-949
45. Petrzykat A., and Douglas S. Gone gene fishing: how to catch novel marine antimicrobials. Trends Biotechnol. 21 (2003) 362-369